
A REIT With Great V...


| GSK | Sector Avg. | S&P 500 |
|---|---|---|
| 15.73 | 19.50 | 17.70 |
| 3 Mo | 1 Yr | 3 Yr |
|---|---|---|
| 17.60 | 18.37 | 58.20 |
| GROWTH | 12 Mo | 3 Yr | CAGR |
|---|---|---|---|
| Revenue | 0.50 | -0.07 | -0.02 |
| Net Income | 0.00 | 0.00 | |
| EPS | -7.70 | -0.15 | -0.05 |
| EBITDA | 11.76B |
| REVENUE | 42.71B |
| Qtr (06/13) | Qtr (09/13) | FY (12/13) | FY (12/14) | |
|---|---|---|---|---|
| Average Estimate | $0.88 | $0.91 | $3.64 | $4.02 |
| Number of Analysts | 2 | 2 | 7 | 6 |
| High Estimate | $0.89 | $0.93 | $3.79 | $4.32 |
| Low Estimate | $0.88 | $0.88 | $3.60 | $3.78 |
| Prior Year | $0.82 | $0.85 | $3.58 | $3.64 |
| Growth Rate (Year over Year) | 7.93% | 6.47% | 1.76% | 10.26% |